[ad_1]
From the point of view of dealing with the epidemic, the government’s restrictive measures dynamically introduced, including the new rules ordered from midnight on Tuesday, are “acceptable and healthy,” said the rector of Semmelweis University in Pécs.
According to the MTI report, Béla Merkely said at a conference held at the University of Pécs (PTE) on the occasion of the Hungarian Science Festival – in an unusual way online – on Szentágothai Day,
In light of the effect of the restrictions, repeated loosening can only be decided at a later stage. He confirmed that the epidemic can only be stopped if a significant part of the population is infected or if a sufficient number of effective vaccines are available.
He stressed that already in the spring it became clear in the defense that the cooperation of Hungarian medical universities is extremely important. As an example, he mentioned that in May a representative coronavirus screening test was carried out in half a thousand settlements nationwide, in which almost 18,000 people participated, in which four Hungarian medical trainers participated.
Describing the results of this research in detail, he said: the survey predicted that since the first wave of the virus had barely affected the country, there would be a much higher number of infected people in the country later in the second wave; now we can witness this
– He said. He added that at the time of the national survey in May, it was observed that only five percent of those who went to see a doctor with upper respiratory complaints were patients with coronavirus, however, based on current medical experience,
one in two people with such symptoms became infected with the virus, while a tenth of the asymptomatic patients examined also suffered from the disease.
He said that the positivity of all tests is consistently above twenty percent, or up to thirty percent for medical universities, because those that produce the symptom are the ones that are tested the most, contact research is no longer available. performed at the current stage of the epidemic and full and regular examinations have not yet been conducted.
According to Béla Merkely, regional age-related data showing the prevalence of infection, which can be determined after the peak of the current phase of the epidemic, will help decide to what extent future vaccines and vaccination strategy should be administered. . the need for another future representative survey, similar to the one in May.
At the event, József Bódis, Secretary of State for Higher Education, Innovation and Professional Training of the Ministry of Innovation and Technology (ITM), recalled about the coronavirus epidemic that the ministry has launched more than twenty research projects to prevent the spread of the virus. completed and some of them are in an advanced state.
He reported on the development of ventilators in three different projects, the production of masks, the therapeutic use of plasma from people with the disease, the development of clinical trials of remdesivir, which have proven to be effective in treating the disease, and the development of various vaccines.
József Bódis drew attention to the fact that today Hungary is ready to fight the epidemic: there is no shortage of masks, there is a sufficient amount of disinfectant and many test methods are available, specialists have up-to-date data and we have effective medicines . He drew attention to the fact that through the Call for Proposals to Invest in the Future, research and development projects that are important from a public health point of view can receive 7 billion HUF from the National Research Fund. , Development and Innovation.
In addition to the lectures, the ninth scientific ceremony also commemorated the appointment of the János Szentágothai Research Center of the University of Pécs with the award ceremony. Judit Pongrácz, a professor at the Faculty of Pharmacy at the University of Pécs (PTE), received the Szentágothai Prize, Tamás Öller and researcher at the Research Center János Szentágothai (SZJK) received the junior version of the award, the statement read.
[ad_2]
